全文获取类型
收费全文 | 718篇 |
免费 | 27篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 30篇 |
妇产科学 | 13篇 |
基础医学 | 65篇 |
口腔科学 | 37篇 |
临床医学 | 76篇 |
内科学 | 111篇 |
皮肤病学 | 13篇 |
神经病学 | 22篇 |
特种医学 | 101篇 |
外科学 | 136篇 |
综合类 | 53篇 |
预防医学 | 29篇 |
眼科学 | 6篇 |
药学 | 55篇 |
肿瘤学 | 19篇 |
出版年
2022年 | 4篇 |
2021年 | 6篇 |
2020年 | 5篇 |
2018年 | 13篇 |
2017年 | 4篇 |
2015年 | 8篇 |
2014年 | 10篇 |
2013年 | 29篇 |
2012年 | 8篇 |
2011年 | 18篇 |
2010年 | 29篇 |
2009年 | 27篇 |
2008年 | 10篇 |
2007年 | 36篇 |
2006年 | 34篇 |
2005年 | 23篇 |
2004年 | 28篇 |
2003年 | 15篇 |
2002年 | 13篇 |
2001年 | 14篇 |
2000年 | 17篇 |
1999年 | 10篇 |
1998年 | 29篇 |
1997年 | 31篇 |
1996年 | 39篇 |
1995年 | 24篇 |
1994年 | 12篇 |
1993年 | 25篇 |
1992年 | 17篇 |
1991年 | 10篇 |
1990年 | 10篇 |
1989年 | 23篇 |
1988年 | 12篇 |
1987年 | 16篇 |
1986年 | 14篇 |
1985年 | 13篇 |
1984年 | 11篇 |
1983年 | 8篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 8篇 |
1974年 | 5篇 |
1972年 | 12篇 |
1970年 | 5篇 |
1969年 | 4篇 |
排序方式: 共有767条查询结果,搜索用时 31 毫秒
31.
32.
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells 总被引:8,自引:1,他引:8
Uckun FM; Fauci AS; Heerema NA; Song CW; Mehta SR; Gajl-Peczalska K; Chandan M; Ambrus JL 《Blood》1987,70(4):1020-1034
The purpose of this study was to analyze the expression of B cell growth factor (BCGF) receptors and to elucidate the biologic effects of biochemically purified natural BCGF at the B cell precursor stage of human B lineage lymphoid differentiation. The specific binding of radioiodinated high-mol-wt BCGF (125I-HMW-BCGF) and low-molecular-wt BCGF (125I-LMW-BCGF) to fresh marrow blasts from B cell precursor acute lymphoblastic leukemia (ALL) patients was initially investigated. The estimated number of radioiodinated BCGF molecules bound per blast ranged from undetectable to 24.3 X 10(3) for HMW-BCGF, and from 11.5 X 10(3) to 457.8 X 10(3) for LMW-BCGF. In 3H-TdR incorporation assays, 75% of cases showed a significant response to LMW-BCGF with a median stimulation index of 9.3. By comparison, only 33% of cases showed a significant response to HMW-BCGF with a median stimulation index of 2.4. Subsequently, B cell precursor colony assays were performed to assess and compare the biologic effects of BCGF on leukemic B lineage lymphoid progenitor cells. Among 28 cases studied, 57% responded to both HMW-BCGF and LMW-BCGF, 21% responded only to LMW-BCGF, and the remaining cases showed no proliferative response to either growth factor. The response patterns of virtually pure populations of FACS- sorted leukemic B cell precursors were essentially identical to the proliferative responses of unsorted leukemic B-cell precursors. Synergistic effects between HMW-BCGF and LMW-BCGF were observed in 80% of the cases that responded to both. The numbers of cell-bound radioiodinated BCGF molecules, the stimulation indices, as well as the number of B cell precursor colonies in BCGF-stimulated cultures showed a marked interpatient variation. Patients with structural chromosomal abnormalities (SCAs) involving 12p11-13 or patients with a Philadelphia chromosome showed a greater HMW-BCGF response at the level of leukemic progenitor cells than did other patients (P = .02). The LMW-BCGF response was significantly greater for patients with SCA than for patients without SCA (P = .04). The response of leukemic progenitor cells to HMW-BCGF or LMW-BCGF did not correlate with sex, age, disease status, FAB morphology, WBC at diagnosis, or immunophenotype. To our knowledge, this study represents the first detailed analyses of BCGF receptor expression and BCGF effects in B cell precursor ALL. The data presented provide direct evidence for the expression of functional receptors for both HMW-BCGF and LMW-BCGF in B cell precursor ALL. 相似文献
33.
34.
We describe a patient with Waldenstrom macroglobulinemia who presented with a lymphocytic pleural effusion. Pleural involvement in Waldenstrom macroglobulinemia is very rare. In addition, to our knowledge, there are no reports in the literature in which a primary diagnosis was made on the basis of pleural fluid analysis. The presence of small lymphocytes in serous cavity fluid can pose great difficulty in the differentiation between a low-grade lymphoproliferative disorder and reactive lymphocytosis. The diagnosis of malignancy in this case was established on the basis of morphologic testing, flow cytometry, and the detection of B-cell immunoglobulin gene rearrangement. 相似文献
35.
Although renal abnormalities have been described in children with Alagille's syndrome, cystic kidney disease has not often been documented, and then usually only at necropsy. Three children with Alagille's syndrome are described, in two of whom a unilateral multicystic dysplastic kidney was detected by prenatal ultrasound; in the other, a solitary cortical cyst was found later in childhood. All have normal renal function, growth, and liver synthetic function but continue to have clinical and biochemical signs of cholestasis. These cases show that unilateral cystic kidney disease with or without renal dysplasia may be associated with Alagille's syndrome, that the clinical course is not necessarily unfavourable, and that Alagille's syndrome should be included in the differential diagnosis of cystic kidney disorders associated with cholestatic liver disease. Patients with Alagille's syndrome should be evaluated by renal ultrasound. 相似文献
36.
DePalma A 《Seminars in urologic oncology》2000,18(3):178-181
Prostate Cancer Shared Decision, a CD-ROM program produced with the guidance of leading prostate cancer specialists, educates prostate cancer patients and suggests possible treatments. As the first portable, interactive prostate cancer decision-making tool, Prostate Cancer Shared Decision offers expert, plain-language explanations of prostate anatomy, cancer diagnosis, and treatment options. Through answers to lifestyle and attitude questions entered into a series of user-friendly questionnaire screens, Prostate Cancer Shared Decision helps patients understand their disease and feel comfortable with their treatment decision. This type of educational tool is representative of the new technology that is becoming available to patients with prostate cancer. 相似文献
37.
38.
39.
40.